(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.30%22.57B | -4.86%46.26B | -11.76%22.06B | -6.42%48.62B | 0.06%25B | 32.72%51.96B | 46.79%24.98B | -8.98%39.15B | -19.14%17.02B | 5.47%43.01B |
Operating income | 2.30%22.57B | -4.86%46.26B | -11.76%22.06B | -6.42%48.62B | 0.06%25B | 32.72%51.96B | 46.79%24.98B | -8.98%39.15B | -19.14%17.02B | 5.47%43.01B |
Cost of sales | -1.53%-21.67B | 2.83%-45.54B | 8.11%-21.34B | 2.09%-46.87B | -1.45%-23.22B | -29.91%-47.87B | -44.98%-22.89B | 5.19%-36.85B | 15.55%-15.79B | -14.33%-38.86B |
Operating expenses | -1.53%-21.67B | 2.83%-45.54B | 8.11%-21.34B | 2.09%-46.87B | -1.45%-23.22B | -29.91%-47.87B | -44.98%-22.89B | 5.19%-36.85B | 15.55%-15.79B | -14.33%-38.86B |
Gross profit | 25.15%900.18M | -59.08%717.29M | -59.51%719.27M | -57.16%1.75B | -15.17%1.78B | 77.60%4.09B | 70.09%2.09B | -44.50%2.3B | -47.68%1.23B | -38.87%4.15B |
Selling expenses | 1.87%-56.94M | -19.88%-139.32M | -8.45%-58.02M | 24.04%-116.22M | 34.92%-53.5M | -64.21%-153M | -110.32%-82.21M | -13.18%-93.17M | -13.50%-39.09M | 4.07%-82.32M |
Administrative expenses | 1.35%-360.68M | 10.74%-832.93M | 16.86%-365.6M | -17.82%-933.12M | -66.57%-439.72M | -16.64%-791.97M | 11.98%-263.99M | -4.83%-678.99M | -0.66%-299.93M | 11.96%-647.68M |
Research and development expenses | -15.21%-192.68M | -2.30%-353.87M | -7.09%-167.24M | -107.68%-345.9M | -147.45%-156.17M | ---166.55M | ---63.11M | ---- | ---- | ---- |
Impairment and provision | -186.56%-14.83M | 68.42%-99.5M | 142.18%17.14M | -346.77%-315.05M | -9,396.11%-40.62M | -8,565.43%-70.52M | 104.99%437K | 115.92%833K | -118.05%-8.76M | -102.40%-5.23M |
-Other impairment is provision | -186.56%-14.83M | 68.42%-99.5M | 142.18%17.14M | -346.77%-315.05M | -9,396.11%-40.62M | -8,565.43%-70.52M | 104.99%437K | 115.92%833K | -118.05%-8.76M | -102.40%-5.23M |
Special items of operating profit | -110.45%-26.79M | -42.33%595.85M | -55.39%256.32M | 232.93%1.03B | 31.16%574.53M | -20.44%310.35M | 373.78%438.04M | -41.58%390.1M | -50.78%92.46M | 144.23%667.79M |
Operating profit | -38.22%248.27M | -110.45%-112.48M | -75.80%401.87M | -66.59%1.08B | -21.78%1.66B | 67.48%3.22B | 117.58%2.12B | -52.92%1.92B | -55.74%975.79M | -36.80%4.08B |
Financing income | 31.61%145.65M | -5.15%224.35M | -4.50%110.67M | 4.59%236.53M | 28.16%115.88M | 38.06%226.15M | 10.85%90.42M | 122.11%163.8M | 179.83%81.56M | 106.46%73.75M |
Financing cost | -2.59%-252.33M | 24.05%-425.06M | 13.63%-245.96M | -45.69%-559.67M | -60.67%-284.78M | -120.66%-384.15M | -43.85%-177.24M | -21.46%-174.09M | -28.91%-123.21M | 11.15%-143.33M |
Share of profits of associates | 362.63%1.52M | -145.36%-1.38M | 68.28%-578K | 128.96%3.04M | -379.88%-1.82M | -682.70%-10.5M | -87.82%651K | -102.64%-1.34M | -34.94%5.34M | 2,712.26%50.7M |
Earning before tax | -46.20%143.1M | -141.62%-314.57M | -82.15%266M | -75.23%755.73M | -26.85%1.49B | 59.68%3.05B | 116.82%2.04B | -52.99%1.91B | -56.23%939.48M | -35.47%4.06B |
Tax | -298.11%-20.07M | 112.78%118.36M | 103.90%10.13M | 110.93%55.62M | 38.18%-260.08M | -75.41%-508.68M | -174.93%-420.7M | 63.65%-289.99M | 66.64%-153.02M | 44.55%-797.87M |
After-tax profit from continuing operations | -55.45%123.03M | -124.18%-196.21M | -77.55%276.14M | -68.09%811.36M | -23.90%1.23B | 56.87%2.54B | 105.51%1.62B | -50.38%1.62B | -53.40%786.46M | -32.79%3.27B |
Earning after tax | -55.45%123.03M | -124.18%-196.21M | -77.55%276.14M | -68.09%811.36M | -23.90%1.23B | 56.87%2.54B | 105.51%1.62B | -50.38%1.62B | -53.40%786.46M | -32.79%3.27B |
Minority profit | 573.30%28.97M | -1,049.06%-36.52M | -119.82%-6.12M | -92.19%3.85M | -31.85%30.88M | 41.68%49.24M | 294.24%45.31M | -38.61%34.75M | -46.26%11.49M | -28.19%56.62M |
Profit attributable to shareholders | -66.67%94.06M | -119.78%-159.69M | -76.46%282.26M | -67.62%807.51M | -23.67%1.2B | 57.20%2.49B | 102.71%1.57B | -50.59%1.59B | -53.49%774.97M | -32.86%3.21B |
Basic earnings per share | -62.50%0.03 | -118.18%-0.04 | -75.00%0.08 | -67.16%0.22 | -23.81%0.32 | 55.81%0.67 | 100.00%0.42 | -50.00%0.43 | -53.33%0.21 | -34.35%0.86 |
Diluted earnings per share | -62.50%0.03 | -118.18%-0.04 | -75.00%0.08 | -67.16%0.22 | -23.81%0.32 | 55.81%0.67 | 100.00%0.42 | -50.00%0.43 | -53.33%0.21 | -34.35%0.86 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data